[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100230180":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":20,"centralContacts":20,"locations":21,"responsibleParty":34,"collaborators":20,"id":38,"slug":39,"hasResults":40,"nctId":41,"briefTitle":42,"officialTitle":43,"acronym":44,"eligibilityCriteria":45,"healthyVolunteers":46,"sex":47,"minAge":48,"maxAge":49,"enrollmentInfo":50,"targetDuration":20,"studyType":53,"phases":54,"briefSummary":56,"conditions":57,"keywords":59,"overallStatus":65,"whyStopped":20,"lastUpdateSubmitDate":66,"lastUpdatePostDateStruct":67,"startDateStruct":70,"completionDateStruct":72,"leadSponsor":74,"locationsCount":75},{"fullName":5,"class":6},"Fundacion Clinic per a la Recerca Biomédica","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Gadobutrol","EXPERIMENTAL","Gadobutrol in Healthy volunteers",[13],"Drug: gadobutrol",[15],{"type":16,"name":17,"description":18,"armGroupLabels":19,"otherNames":20},"DRUG","gadobutrol","Gadobutrol administration in healthy volunteers",[9],null,[22],{"facility":23,"status":20,"city":24,"state":24,"zip":25,"country":26,"countryCode":27,"cosmosGeoPoint":28,"geoPoint":33,"contacts":20},"Hospital Clinic of Barcelona","Barcelona","08036","Spain","ES",{"type":29,"coordinates":30},"Point",[31,32],2.15899,41.38879,{"lat":32,"lon":31},{"type":35,"investigatorFullName":36,"investigatorTitle":37,"investigatorAffiliation":5,"oldNameTitle":20,"oldOrganization":20},"PRINCIPAL_INVESTIGATOR","Sara Varea","Clinical Research Manager","100230180","phase-1-validation-of-the-efficacy-of-the-tool-gimias-for-the-assessment-of-left-atrial-fibrosis-in-a-group-of-healthy-volunteers-restore-hv-100230180",false,"NCT02274246","Validation of the Efficacy of the Tool GIMIAS® for the Assessment of Left Atrial Fibrosis in a Group of Healthy Volunteers (RESTORE-HV)","GIMIAS® Tool Validation for the Detection of Left Atrium Fibrosis Through Late Enhancement Magnetic Resonance Image Processing. Pattern Determination in a Cohort of Healthy Volunteers","RESTORE-HV","Inclusion Criteria:\n\n* Healthy volunteers capable of being subjected to the prespecified tests of the study.\n* Healthy volunteers that sign the informed consent after being informed.\n\nExclusion Criteria:\n\n* Healthy volunteers with:\n* A medical history of atrial fibrillation, hypertension or diabetes mellitus.\n* A medical history of heart disease, structural, ischemic or arrhythmic.\n* A medical history of chronic obstructive pulmonary disease\u002Fobstructive sleep apnoea\u002Fhypopnoea syndrome\n* Sport habits: intense sport activities during three or more hours in a week\n* Any assumption that contraindicates the magnetic resonance and\u002For the use of gadolinium or other contrast mediums, including a medical history of previous allergic or not allergic reactions with the use of gadolinium or other contrast mediums, bronchial asthma or allergic diseases.\n* Pregnancy or breast feeding.",true,"ALL","18 Years","35 Years",{"count":51,"type":52},9,"ACTUAL","INTERVENTIONAL",[55],"PHASE1","The purpose of this study is to validate the technique for the detection of left atrial fibrosis through segmentation of endocardial and epicardium landmarks of the images obtained with 3 Tgadobutrol-enhanced magnetic resonance with the software GIMIAS® in a cohort of healthy volunteers, without atrial fibrillation or known cardiovascular risk factors.",[58],"Left Atrial Fibrosis",[60,61,62,63,64],"Segmentation","GIMIAS® program","Atrial fibrillation","Left atrial fibrosis","Healthy volunteers","COMPLETED","2015-08-17",{"date":68,"type":69},"2015-08-19","ESTIMATED",{"date":71,"type":20},"2014-11",{"date":73,"type":52},"2015-03",{"name":5,"class":6},1]